ResMed Inc. Common Stock (RMD)

About RMD

ResMed Inc. engages in the digital health and cloud-connected medical devices business in the United States and internationally. It operates in two segments, Sleep and Breathing Health, and Residential Care Software. The company offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, r…

Sector

Health Care

Industry

Medical/Dental Instruments

Employees

11,370

Website

www.resmed.com/

Fundamentals

1-day range

$235.52$241.03

Market cap

$31.21B

P/E (trailing)

21.47

P/E (forward)

18.18

EPS (trailing)

$10.44

Dividend yield

1.25%

Beta

0.75

Avg. volume

1.52M

Ex-dividend date

August 20, 2026

Dividend pay date

September 24, 2026

Forecasts

16 analyst ratings

ResMed Inc. Common Stock Competitors

Chosen by industry and closest market cap.

• RMD

  ResMed Inc. Common Stock

  $240.24

  ▲ 1.90%
  Market cap $31.21BP/E 21.47
  $180.27$285.08
• DXCM

  DexCom Inc. Common Stock

  $90.8

  ▲ 1.69%
  Market cap $32.95BP/E 34.53
  $54.11$92.59
• BDX

  Becton Dickinson and Company Common Stock

  $189.6

  ▲ 0.78%
  Market cap $46.90BP/E 53.21
  $127.59$193.07
• BAX

  Baxter International Inc. Common Stock

  $26.12

  ▲ 0.77%
  Market cap $14.53BP/E —
  $15.73$30
• PODD

  Insulet Corporation Common Stock

  $145.15

  ▲ 1.21%
  Market cap $11.75BP/E 27.05
  $126.4$354.88
• GMED

  Globus Medical Inc. Class A Common Stock

  $83.06

  ▲ 0.63%
  Market cap $11.06BP/E 21.55
  $54.15$101.4
• GKOS

  Glaukos Corporation Common Stock

  $179.56

  ▼ 1.29%
  Market cap $10.08BP/E —
  $73.16$191.62

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• Rothschild & Co Initiates Coverage of ResMed (RMD) with Neutral Recommendation
  Fintel · 8/20/2026
• Rothschild & Co Initiates Coverage On ResMed with Neutral Rating, Announces Price Target of $230
  benzinga · 8/19/2026
• Moderna upgraded, Baidu downgraded: Wall Street's top analyst calls
  Yahoo · 8/19/2026
• Rothschild & Co Initiates Coverage On ResMed with Neutral Rating, Announces Price Target of $230
  Benzinga · 8/19/2026
• Resmed Announces Appointment of Carol Burt as Lead Director and Planned Retirement of Director Ron Taylor
  Yahoo · 8/17/2026
• ResMed’s (RMD) Sleep Business Booms Even As One Product Stumbles
  Yahoo · 8/17/2026
• Dividend Announcements: August 1-7, 2026
  SeekingAlpha · 8/16/2026
• The 5 Most Interesting Analyst Questions From ResMed’s Q2 Earnings Call
  Yahoo · 8/15/2026
• Dividend Champion, Contender, And Challenger Highlights: Week August 16
  SeekingAlpha · 8/14/2026

• Michael J. Farrell · August 7, 2026 · Option Exercise

  5.0K @ $146.34
• Michael J. Farrell · August 7, 2026 · Sale

  5.0K @ $205.69
• Peter C. Farrell · August 5, 2026 · Sale

  8.0K @ $225
• Michael J. Farrell · July 7, 2026 · Option Exercise

  5.0K @ $146.34
• Michael J. Farrell · July 7, 2026 · Sale

  5.0K @ $218.55
• Michael J. Farrell · June 8, 2026 · Option Exercise

  5.0K @ $146.34
• Michael J. Farrell · June 8, 2026 · Sale

  5.0K @ $193.96
• Michael J. Rider · June 1, 2026 · Tax Withholding

  269 @ $190.57
• Michael J. Farrell · May 7, 2026 · Option Exercise

  5.0K @ $146.34
• Michael J. Farrell · May 7, 2026 · Sale

  5.0K @ $207.82
• Michael J. Farrell · April 7, 2026 · Option Exercise

  5.0K @ $146.34
• Michael J. Farrell · April 7, 2026 · Sale

  5.0K @ $225.5
• Brett Sandercock · April 1, 2026 · Sale

  1.0K @ $224.31
• Peter C. Farrell · April 1, 2026 · Sale

  2.0K @ $225
• Michael J. Farrell · March 9, 2026 · Option Exercise

  5.0K @ $146.34

Institutional Ownership

March 31, 2026

Total shares held

88.10M

Total value held

$19.20B

Institutional holders

931